Harm H. Westdorp

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

NEOadjuvant Dendritic cell therapy added to first line standard of care in advanced epithelial Ovarian Cancer (NEODOC): protocol of a first-in-human, exploratory, single-centre phase I/II trial in the Netherlands.

NEOadjuvant Dendritic cell therapy added to first line standard of care in advanced epithelial Ovarian Cancer (NEODOC): protocol of a first-in-human, exploratory, single-centre phase I/II trial in the Netherlands.

Journal: BMJ open

Published: November 10, 2025

Effects of exercise and diet in patients with incurable gastroesophageal cancer: the RADICES study.

Effects of exercise and diet in patients with incurable gastroesophageal cancer: the RADICES study.

Journal: JNCI cancer spectrum

Published: August 29, 2025

STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study.

STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study.

Journal: BMJ open

Published: July 16, 2025

Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity.

Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity.

Journal: Journal for immunotherapy of cancer

Published: April 18, 2025

Cognitive Behavioral Therapy for Cancer-Related Fatigue: A Comparison Between Patients Treated With Curative Intent and Patients With Advanced Cancer.

Cognitive Behavioral Therapy for Cancer-Related Fatigue: A Comparison Between Patients Treated With Curative Intent and Patients With Advanced Cancer.

Journal: Psycho-oncology

Published: March 27, 2025

Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study.

Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study.

Journal: BJC reports

Published: February 13, 2025

Intratumoral Holmium-166 Microsphere Injection in Patients with Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Center, Single-Arm, Open-Label Feasibility and Safety Study.

Intratumoral Holmium-166 Microsphere Injection in Patients with Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Center, Single-Arm, Open-Label Feasibility and Safety Study.

Journal: Digestive surgery

Published: December 14, 2024

Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial.

Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 13, 2024

Exploring the effects of exercise on immune cell function and tumour infiltration in patients with breast cancer receiving neoadjuvant chemotherapy - a feasibility trial.

Exploring the effects of exercise on immune cell function and tumour infiltration in patients with breast cancer receiving neoadjuvant chemotherapy - a feasibility trial.

Journal: Brain, behavior, & immunity - health

Published: July 17, 2024

Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population-based study in the Netherlands.

Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population-based study in the Netherlands.

Journal: International journal of cancer

Published: July 02, 2024

Proteinuria, Blinded by Bright Light.

Proteinuria, Blinded by Bright Light.

Journal: Clinical chemistry

Published: June 08, 2024

Impact of TP53 loss-of-function alterations on the response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients.

Impact of TP53 loss-of-function alterations on the response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients.

Journal: Theranostics

Published: February 01, 2024

Showing 1-12 of 50

Last Updated: 09/26/2026